TG4-155
CAY-17639-5 5 mg
Data Sheet: 
SDS:
SDS:
CAS
1164462-05-8
Formulation
A crystalline solid
Purity
≥98%
MW
394,5
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
A selective, brain penetrant EP2 antagonist (KB = 2.4 nM); blocks the induced expression of inflammatory markers in microglial cells treated with butaprost; reduces neurodegeneration in a mouse model of status epilepticus; inhibits proliferation and invasion in cancer cells treated with butaprost
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
